Found: 35
Select item for more details and to access through your institution.
Synaptic proteins in CSF relate to Parkinson's disease stage markers.
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0008-2
- By:
- Publication type:
- Article
Distribution and impact on quality of life of the pain modalities assessed by the King's Parkinson's disease pain scale.
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0009-1
- By:
- Publication type:
- Article
Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0007-3
- By:
- Publication type:
- Article
Non motor symptoms in progressive supranuclear palsy: prevalence and severity.
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0037-x
- By:
- Publication type:
- Article
Targeted kinase inhibition relieves slowness and tremor in a Drosophila model of LRRK2 Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0036-y
- By:
- Publication type:
- Article
Vertebrate food products as a potential source of prion-like α-synuclein.
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0035-z
- By:
- Publication type:
- Article
Author Correction: Using a smartphone-based self-management platform to support medication adherence and clinical consultation in Parkinson's disease.
- Published in:
- 2017
- By:
- Publication type:
- Correction Notice
The Gordon Research Seminar & Conference on Parkinson's disease: state of the Science 200 years after James Parkinson's essay on the Shaking Palsy.
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0028-y
- By:
- Publication type:
- Article
Paraquat and MPTP induce neurodegeneration and alteration in the expression profile of microRNAs: the role of transcription factor Nrf2.
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0033-1
- By:
- Publication type:
- Article
Falling upward with Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0031-3
- By:
- Publication type:
- Article
Rotigotine transdermal patch and sleep in Parkinson's disease: where are we now?
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0030-4
- By:
- Publication type:
- Article
Parkinson's disease associated with pure ATXN10 repeat expansion.
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0029-x
- By:
- Publication type:
- Article
Mitochondrial impairment in microglia amplifies NLRP3 inflammasome proinflammatory signaling in cell culture and animal models of Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0032-2
- By:
- Publication type:
- Article
Cognitive behavioral therapy for insomnia in Parkinson's disease: a case series.
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0027-z
- By:
- Publication type:
- Article
Validation of the XDP–MDSP rating scale for the evaluation of patients with X-linked dystonia-parkinsonism.
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0026-0
- By:
- Publication type:
- Article
Response inhibition in Parkinson's disease: a meta-analysis of dopaminergic medication and disease duration effects.
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0024-2
- By:
- Publication type:
- Article
Imaging tau pathology in Parkinsonisms.
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0023-3
- By:
- Publication type:
- Article
Embryonic development of selectively vulnerable neurons in Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0022-4
- By:
- Publication type:
- Article
Use of a self-rating scale of the nature and severity of symptoms in Parkinson's Disease (PRO-PD): Correlation with quality of life and existing scales of disease severity.
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0021-5
- By:
- Publication type:
- Article
Variable frequency of LRRK2 variants in the Latin American research consortium on the genetics of Parkinson's disease (LARGE-PD), a case of ancestry.
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0020-6
- By:
- Publication type:
- Article
A multifactorial study on nutritional status, binge eating and physical activity as main factors directly influencing body weight in Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0018-0
- By:
- Publication type:
- Article
Synergistic effects of influenza and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) can be eliminated by the use of influenza therapeutics: experimental evidence for the multi-hit hypothesis.
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0019-z
- By:
- Publication type:
- Article
Imaging Parkinson's disease below the neck.
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0017-1
- By:
- Publication type:
- Article
Palliative care for Parkinson's disease: suggestions from a council of patient and carepartners.
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0016-2
- By:
- Publication type:
- Article
Integrated molecular landscape of Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0015-3
- By:
- Publication type:
- Article
Early-onset parkinsonism in a pedigree with phosphoglycerate kinase deficiency and a heterozygous carrier: do PGK-1 mutations contribute to vulnerability to parkinsonism?
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0014-4
- By:
- Publication type:
- Article
Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson's disease trial.
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0013-5
- By:
- Publication type:
- Article
Using a smartphone-based self-management platform to support medication adherence and clinical consultation in Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-016-0003-z
- By:
- Publication type:
- Article
Insomnia and somnolence in idiopathic RBD: a prospective cohort study.
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0011-7
- By:
- Publication type:
- Article
The gut-brain axis: is intestinal inflammation a silent driver of Parkinson's disease pathogenesis?
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-016-0002-0
- By:
- Publication type:
- Article
LRRK2 levels in immune cells are increased in Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0010-8
- By:
- Publication type:
- Article
Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson's disease: evidence for dopaminergic basis?
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-016-0006-9
- By:
- Publication type:
- Article
Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses.
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0012-6
- By:
- Publication type:
- Article
Excessive early-life dietary exposure: a potential source of elevated brain iron and a risk factor for Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-016-0004-y
- By:
- Publication type:
- Article
Combined immunotherapy with "anti-insulin resistance" therapy as a novel therapeutic strategy against neurodegenerative diseases.
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-016-0001-1
- By:
- Publication type:
- Article